NKF Measure Gains Endorsement to Advance Early Detection of Kidney Disease
The National Kidney Foundation (NKF) announced that the Partnership for Quality Measurement (PQM) has endorsed its measure designed to promote earlier detection of chronic kidney disease.
New York – The National Kidney Foundation (NKF) announced that the Partnership for Quality Measurement (PQM) has endorsed its measure aimed at advancing the earlier detection of chronic kidney disease (CKD). The NKF's expanded Kidney Health Evaluation measure promotes annual testing for adults with diabetes and/or high blood pressure.
The endorsement by PQM represents a significant step in NKF's efforts to improve the identification and management of kidney disease. The measure focuses on screening patients at higher risk of developing CKD, including individuals with diabetes and hypertension.
Early detection of chronic kidney disease is crucial for slowing disease progression and preventing severe complications such as kidney failure. The NKF has been actively working to raise awareness and provide tools for healthcare professionals to enhance diagnosis.
Partnership for Quality Measurement is an organization that evaluates and endorses healthcare measures to ensure their quality and effectiveness. With this endorsement, the NKF's measure is expected to gain broader recognition and potential adoption within healthcare systems.